DarioHealth announces strategic reorganization

DarioHealth announced a strategic reorganization designed to streamline leadership and focus the organization on accelerating its commercialization efforts. To achieve this goal, DarioHealth is transitioning to a flatter organizational model. The President role will be eliminated, and dedicated C-level positions will be established for each core function, reporting directly to the CEO- The newly created role of Chief Commercial Officer will be in addition to the existing C-Level roles in the Company. The Company believes that this structure fosters a more collaborative environment and ensures clear lines of communication which are essential for driving successful commercialization initiatives. DarioHealth also announced the appointment of Steven Nelson as its Chief Commercial Officer. Nelson will oversee Dario’s global commercial activities, including growth strategy, sales, client management, marketing, strategic partnerships, and expansion into new markets. Nelson brings over two decades of experience building and scaling technology-centric healthcare companies.In a mutual agreement, Rick Anderson will step down in his role as President of the Company and will join the advisory board of DarioHealth. In conjunction with Mr. Nelson’s appointment as Chief Commercial Officer, he was granted a non-qualified stock option award to purchase 500,000 shares of the Company’s common stock, a non-qualified performance-based stock option award to purchase up to an additional 400,000 shares of the Company’s common stock during each of the fiscal years ending December 31, as well as additional non-qualified performance-based stock option award to purchase up to an additional 450,000 shares of the Company’s common stock during each of the fiscal years ending December 31, 2025.